The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

Birkedal-Hansen, 1995, Proteolytic remodeling of extracellular matrix, Curr. Opin. Cell Biol., 7, 728, 10.1016/0955-0674(95)80116-2

Brew, 2000, Tissue inhibitors of metalloproteinases, evolution, structure and function, Biochim. Biophys. Acta, 1477, 267, 10.1016/S0167-4838(99)00279-4

Brown, 1984, Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080, EMBO J., 3, 1321, 10.1002/j.1460-2075.1984.tb01970.x

Canete-Soler, 1995, Developmental expression of MMP-9 (Gelatinase B) mRNA in mouse embryos, Dev. Dyn., 204, 30, 10.1002/aja.1002040105

Caterina, 2000, Inactivating mutation of the mouse tissue inhibitor of metalloproteinase-2 (Timp-2) gene alters proMMP-2 activation, J. Biol. Chem., 275, 26416, 10.1074/jbc.M001271200

Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contribute to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2

Davies, 1993, Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion, Cancer Res., 53, 5365

Ellerbroek, 1999, Membrane associated matrix metalloproteinases in metastasis, Bioessays, 21, 940, 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.0.CO;2-J

Fagan, 1981, Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA, J. Biol. Chem., 256, 520, 10.1016/S0021-9258(19)70169-0

Folkman, 1996, Blood vessel formation, Cell, 87, 1153, 10.1016/S0092-8674(00)81810-3

Furumoto, 2001, RECK gene expression in hepatocellular carcinoma, Correlation with invasion-related clinicopathological factors and its clinical significance, Hepatology, 33, 189, 10.1053/jhep.2001.21048

Garbisa, 1987, Secretion of type IV collagenolytic protease and metastatic phenotype, induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2–E1a, Cancer Res., 47, 1523

Gomi, 1995, Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions, Neuron, 14, 29, 10.1016/0896-6273(95)90238-4

Hanahan, 1997, Signaling vascular morphogenesis and maintenance, Science, 277, 48, 10.1126/science.277.5322.48

Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7

Hidalgo, 2001, Development of matrix metalloproteinase inhibitors in cancer therapy, J. Natl. Cancer Inst., 93, 178, 10.1093/jnci/93.3.178

Howard, 1978, Decreased levels of collagen mRNA in rous sarcoma virus-transformed chick embryo fibroblasts, J. Biol. Chem., 253, 5869, 10.1016/S0021-9258(17)30349-6

Ikeda, 2000, Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor, Clin. Cancer Res., 6, 3290

Itoh, 1997, Unaltered secretion of β-amyloid precursor protein in gelatinase A (Matrix Metalloproteinase 2)-deficient mice, J. Biol. Chem., 272, 22389, 10.1074/jbc.272.36.22389

Kahari, 1999, Matrix metalloproteinases and their inhibition in tumour growth and invasion, Ann. Med., 31, 34, 10.3109/07853899909019260

Kitayama, 1989, A ras-related gene with transformation suppressor activity, Cell, 56, 77, 10.1016/0092-8674(89)90985-9

Kinoshita, 1997, Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures, Genes Dev., 11, 1535, 10.1101/gad.11.12.1535

Kinoshita, 1998, TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads, J. Biol. Chem., 273, 16098, 10.1074/jbc.273.26.16098

Knight, 1992, A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases, FEBS Lett., 296, 263, 10.1016/0014-5793(92)80300-6

Lohler, 1984, Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesechymal cell death, Cell, 38, 597, 10.1016/0092-8674(84)90514-2

Matsuo, 1999, Preservation of pathological tissue specimens by freeze-drying for immunohisochemical staining and various molecular biological analyses, Pathol. Int., 49, 383, 10.1046/j.1440-1827.1999.00887.x

Nagase, 1999, Matrix metalloproteinases, J. Biol. Chem., 274, 21491, 10.1074/jbc.274.31.21491

Niwa, 1991, Efficient selection for high-expression transfectants with a novel eukaryotic vector, Gene, 108, 193, 10.1016/0378-1119(91)90434-D

Noda, 1989, Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes, Proc. Natl. Acad. Sci. USA, 86, 162, 10.1073/pnas.86.1.162

Nothnick, 1997, Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene, Biol. Reprod., 56, 1181, 10.1095/biolreprod56.5.1181

Ohuchi, 1997, Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem., 272, 2446, 10.1074/jbc.272.4.2446

Pei, 1996, Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity, J. Biol. Chem., 271, 9135, 10.1074/jbc.271.15.9135

Plantefaber, 1989, Changes in integrin receptors on oncogenically transformed cells, Cell, 56, 281, 10.1016/0092-8674(89)90902-1

Reponen, 1992, Molecular cloning of murine 72-kDa type IV collagenase and its expression duirng mouse development, J. Biol. Chem., 267, 7856, 10.1016/S0021-9258(18)42592-6

Risau, 1997, Mechanisms of angiogenesis, Nature, 386, 671, 10.1038/386671a0

Sasahara, 1999, Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene, Biochem. Biophys. Res. Commun., 264, 668, 10.1006/bbrc.1999.1552

Sato, 1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells, Nature, 370, 61, 10.1038/370061a0

Schlaeger, 1995, Vascular endothelial cell lineage-specific promoter in transgenic mice, Development, 121, 1089, 10.1242/dev.121.4.1089

Stetler-Stevenson, 1999, Matrix metalloproteinasese in angiogenesis, J. Clin. Inv., 103, 1237, 10.1172/JCI6870

Takahashi, 1996, Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene, Oncogene, 12, 2137

Takahashi, 1998, Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK, Proc. Natl. Acad. Sci. USA, 95, 13221, 10.1073/pnas.95.22.13221

Thant, 1997, c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells, FEBS Lett., 406, 28, 10.1016/S0014-5793(97)00230-5

Vu, 2000, Matrix metalloproteinases, effectors of development and normal physiology, Genes Dev., 14, 2123, 10.1101/gad.815400

Wang, 2000, TIMP-2 is required for efficient activation of proMMP-2 in vivo, J. Biol. Chem., 275, 26411, 10.1074/jbc.M001270200

Werb, 1997, ECM and cell surface proteolysis, regulating cellular ecology, Cell, 91, 439, 10.1016/S0092-8674(00)80429-8

Yagi, 1990, Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection, Proc. Natl. Acad. Sci. USA, 87, 9918, 10.1073/pnas.87.24.9918

Yamamoto, 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro, Cancer Res., 56, 384

Yancopoulos, 2000, Vascular-specific growth factors and blood vessel formation, Nature, 407, 242, 10.1038/35025215